7/29/2019 Daily-equity-report by Epic Research 15.02.13

1/4

-=6HEADLINES

Indian Market

Indian equity markets were down 0.61%

Nifty down by 36.00 pts and settle at5896.95

Sensex down by 110.90 pts at 19497.18

Bank Nifty down by 66.75 pts at12330.00

Global Market

European markets were down with FTSEdown by 38.64 closed at 6320 ,CACdown by 26.57 closed at 3671 and DAXdown by 87.47 closed at 7642.

Dow future was down 53.00 closed at

13905.00

WWW.EPICRESEARCH.CO 09752199966

DAILY EQUITY

NEWSLETTER15

THFEBRUARY 2013

HEADLINES

SBI Q3 net up 4% to Rs 3,396 cr on

lower interest income, provisions fall

Jan WPI inflation at 6.62%; experts say

too early to cheer

Biocon shares rise on insulin products

deal with Mylan

Tata Motors Q3 net may slip 34% on

likely domestic biz loss

7/29/2019 Daily-equity-report by Epic Research 15.02.13

2/4

FIIs and DIIs

CATEGORY DATE BUY SELL NET

FII 14-Feb-13 3365.04 3043.78 321.26

DII 14-Feb-13 1214.65 1463.64 -248.99

NIFTY DAILY PIVOTS

IVOT R4 R3 R2 R1 PP S1 S2 S3 S4

IFTY 6181 6085 5989 5942 5893 5846 5797 5701 5605

WWW.EPICRESEARCH.CO 09752199966

MARKETANALYSIS:

Key benchmark indices extended losses in late trad as index heavyweight Reliance Industries (RIL)extended intraday losses in late trade. The barometer index, BSE Sensex, was provisionally down139.94 points or 0.71%, off about 170 points from the day's high and up almost 25 points from the

day's low.BSE Sensex was down 139.94 points or 0.71% to 19,468.14.CNX Nifty index was down 44.20 points or 0.75% to 5,888.65

Among the 30-share Sensex pack, 19 stocks fell while the rest of them rose.Index heavyweight Reliance Industries (RIL) fell 2.63% to Rs 855.15. The stock hit high of Rs 882.85

and low of Rs 850.25. The stock had hit 52-week high of Rs 954.80 in intraday trade on 21 January

2013. LIC Housing Finance tumbled 6.18% on weak Q3 results. LIC Housing Finance's net interestmargin witnessed a decline on sequential basis to 2.09% in Q3 December 2012 from 2.1 in Q2

September 2012.The gross NPA for the total portfolio stood at 0.74% as on 31 December 2012 and netNPA was 0.45%. Dr Reddy's Laboratories (DRL) declined 1.6% after consolidated net profit declined

29.17% to Rs 363.31 crore on 3.69% growth in total income to Rs 2888.47 crore in Q3 December 2012over Q3 December 2011. Wockhardt fell 2.61% on profit taking after consolidated net profit jumped

101.04% to Rs 427.84 crore on 25.78% growth in net sales to Rs 1435.04 crore in Q3 December 2012

over Q3 December 2011.

STOCKS TO WATCH

BHARTI AIRTEL IDFC MCLEOD RUSSEL INDUSIND BANK

SCRIPS IN BAN PERIOD

WELCORP HDIL

PUNJLYOD

SUZLON

IRB

RENUKA

7/29/2019 Daily-equity-report by Epic Research 15.02.13

3/4

WWW.EPICRESEARCH.CO 09752199966

.

EXPERT OPINION

NIFTY

Nifty looks Bearish

Strategy: Sell on rise

Support:5850

Resistance: 5940

BANK NIFTY

Bank Nifty looks Bearish

Strategy: Sell on rise

Support:12260

Resistance:12390

460

GAINERSANDLOOSERS

PREVIOUSPERFORMANCE

TYPE SCRIP B/S RESULT

CASH VOLTAS S TARGET HIT

CASH ONGC B TARGET HIT

FUTUREALLAHBAD

BANKS SL TRIGGERE

FUTUREINDUSIND

BANKB TARGET HIT

UPCOMINGRESULTS

RATHI STEEL

EDSERVSOFTSYST

INDIACEMENTS

DAILY NIFTY GAINERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHANG

E

GAIL

India334.65 1039.73 328.05 6.60 2.01

Hind

Unilever464.55 2698.87 455.75 8.80 1.93

HDFC

Bank674.80 4421.04 664.20 10.60 1.60

Tata

Steel380.90 7140.39 376.00 4.90 1.30

Asian

Paints4526.10 162.66 4471.05 55.05 1.23

DAILY NIFTY LOOSERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHAN

GE

Siemens 576.20 313.37 604.60 -28.40 -4.7

Bharti

Airtel311.70 4392.04 325.95 -14.25 -4.37

Power

Grid105.70 8349.65 109.90 -4.20 -3.82

BPCL 387.35 1790.70 401.45 -14.10 -3.51

Wipro 395.80 2920.03 409.45 -13.65 -3.33

7/29/2019 Daily-equity-report by Epic Research 15.02.13

4/4

.

MARKET CALLS

CASH

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

MCLEOD RUSSEL BUY 352.40 354.40 357.40 350.40

BHARTI AIRTEL SELL 310.10 308.10 305.10 312.10

FUTURE

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

IDFC SELL 154.20 153.40 151.90 155.20

INDUSIND BANK BUY 442.40 444.40 447.40 440.40

DisclaimerThe information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any

responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on

sources that we consider reliable.

This material is for personal information and based upon it & takes no responsibility

The information given herein should be treated as only factor, while making investment decision. The report does not provide individually

tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and

encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on

the information given in this report, which is in violation of rules and regulations of NSE and BSE.

The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all

estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks

recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views

expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of

the information is the acceptance of this disclaimer.

All Rights Reserved.Investment in equity & bullion market has its own risks.

We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any

financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to

buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls

or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious

Legal Actions can be taken.